thiazolidines has been researched along with Colorectal Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Carnero, A; Fernández-Fernández, MC; García-Heredia, JM; Martinez-Pérez, J; Muñoz-Galván, S; Ortiz, MJ; Peinado-Serrano, J; Rivero, M | 1 |
| Gong, G; He, H; Qi, B; Wang, F; Xiong, L; Xu, X; Zhou, Y | 1 |
| Cha, PH; Choi, KY; Hwang, JH; Kim, KS; Koh, E; Kwak, DK | 1 |
| Abu-Serie, MM; Al-Kubeisi, AK; El-Miligy, MMM; El-Zemity, SR; Hazzaa, AA; Nassra, RA | 1 |
| Cha, PH; Choi, KY | 1 |
| Awad, HM; El-Sayed, WA; El-Sofany, WI; Flefel, EM; Mohamed, AM | 1 |
| Endo, K; Kinouchi, Y; Shiga, H; Shimosegawa, T; Takahashi, S | 1 |
1 review(s) available for thiazolidines and Colorectal Cancer
| Article | Year |
|---|---|
[The management of ulcerative colitis in remission stage and the strategies for colorectal cancer surveillance in ulcerative colitis].
Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Colorectal Neoplasms; Humans; Probiotics; Remission Induction; Salicylates; Tacrolimus; Thiazolidines | 2011 |
6 other study(ies) available for thiazolidines and Colorectal Cancer
| Article | Year |
|---|---|
PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.
Topics: Adult; Aged; Apoptosis; Biomarkers, Pharmacological; Biomarkers, Tumor; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Plasminogen Activator Inhibitor 1; Prognosis; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rectal Neoplasms; Thiazolidines | 2020 |
Identification of novel quinoline analogues bearing thiazolidinones as potent kinase inhibitors for the treatment of colorectal cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Colorectal Neoplasms; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Quinolines; Structure-Activity Relationship; Thiazolidines | 2020 |
APC loss induces Warburg effect via increased PKM2 transcription in colorectal cancer.
Topics: Animals; beta Catenin; Carrier Proteins; Colorectal Neoplasms; Genes, APC; Heterografts; Humans; L-Lactate Dehydrogenase; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondrial Proton-Translocating ATPases; Neoplasm Proteins; Proteomics; Thiazolidines; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Tissue Array Analysis; Warburg Effect, Oncologic; Wnt Signaling Pathway | 2021 |
Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Binding Sites; Catalytic Domain; Cell Line, Tumor; Colorectal Neoplasms; Cyclooxygenase 2; Drug Design; Edema; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Proto-Oncogene Proteins c-pim-1; Rats; Small Molecule Libraries; Structure-Activity Relationship; Thiazolidines | 2021 |
Simultaneous destabilization of β-catenin and Ras via targeting of the axin-RGS domain as a potential therapeutic strategy for colorectal cancer.
Topics: Adenomatous Polyposis Coli Protein; Animals; Axin Protein; beta Catenin; Colorectal Neoplasms; Humans; Mice; Mutation; Protein Binding; ras Proteins; Thiazolidines; Wnt Signaling Pathway | 2016 |
Synthesis and Anticancer Activity of New 1-Thia-4-azaspiro[4.5]decane, Their Derived Thiazolopyrimidine and 1,3,4-Thiadiazole Thioglycosides.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Colorectal Neoplasms; Glycosylation; HCT116 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Male; Prostatic Neoplasms; Spiro Compounds; Structure-Activity Relationship; Thiadiazoles; Thiazolidines; Thioglycosides | 2017 |